Skip to main content
Erschienen in: Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen 1/2021

17.03.2021 | Originalien

Pleiotrope Wirkung von Vitamin D mit Berücksichtigung von COVID-19

verfasst von: PD Dr. med. habil. Stephan H. Scharla

Erschienen in: Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Zusammenfassung

Vitamin D wird aus der Nahrung aufgenommen oder in der Haut unter Einwirkung von UV-Licht gebildet. In der Leber wird 25(OH)-Vitamin D gebildet und in der Niere 1,25(OH)2-Vitamin D, welches als Hormon den Knochen- und Mineralstoffwechsel reguliert.
Außerhalb der Niere besitzen viele Organe Enzyme, um 1,25(OH)2-Vitamin D zu bilden für autokrine und parakrine Wirkungen. Für diese pleiotropen Effekte erscheint eine gleichmäßige Vitamin-D-Versorgung (tägliche Vitamin-D-Supplementation) mit mäßiger Dosierung besser wirksam als hoch dosierte Bolusapplikationen. Neben der klassischen Wirkung von 1,25(OH)2-Vitamin D auf das muskuloskelettale System sind unter den extraskelettalen Wirkungen insbesondere die immunregulatorischen Effekte mittlerweile sehr gut belegt. So kann durch eine gute Vitamin-D-Versorgung das Risiko für respiratorische Infekte vermindert werden, was gerade im Hinblick auf die aktuelle COVID-19(Coronavirus-Erkrankung-19)-Pandemie von Bedeutung erscheint.
Literatur
1.
Zurück zum Zitat Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, DeLuca HF (1995) An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab 80:406–411PubMed Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, DeLuca HF (1995) An investigation of sources of variation in calcium absorption efficiency. J Clin Endocrinol Metab 80:406–411PubMed
2.
Zurück zum Zitat Hollis BW, Wagner CL (2013) The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 98:4619–4628PubMedPubMedCentralCrossRef Hollis BW, Wagner CL (2013) The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. J Clin Endocrinol Metab 98:4619–4628PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Nykjaer A, Dragun D, Walther D et al (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96:507–515PubMedCrossRef Nykjaer A, Dragun D, Walther D et al (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96:507–515PubMedCrossRef
4.
Zurück zum Zitat Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh J, Jurutka PW (2013) Molecular mechanisms of vitamin D action. Calcif Tissue Int 92:77–98PubMedCrossRef Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh J, Jurutka PW (2013) Molecular mechanisms of vitamin D action. Calcif Tissue Int 92:77–98PubMedCrossRef
5.
Zurück zum Zitat Scharla SH, Strong DD, Rosen C, Mohan S, Holick M, Baylink DJ, Linkhart TA (1993) 1,25-dihydroxyvitamin D3 increases secretion of insulin-like growth factor binding protein‑4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP‑4 serum levels in vivo. J Clin Endocrinol Metab 77:1190–1197PubMed Scharla SH, Strong DD, Rosen C, Mohan S, Holick M, Baylink DJ, Linkhart TA (1993) 1,25-dihydroxyvitamin D3 increases secretion of insulin-like growth factor binding protein‑4 (IGFBP-4) by human osteoblast-like cells in vitro and elevates IGFBP‑4 serum levels in vivo. J Clin Endocrinol Metab 77:1190–1197PubMed
6.
Zurück zum Zitat Scharla S (2016) Einfluss von Vitamin D auf Knochen und Muskel. Diabetologe 12:261–268CrossRef Scharla S (2016) Einfluss von Vitamin D auf Knochen und Muskel. Diabetologe 12:261–268CrossRef
7.
Zurück zum Zitat Infante M, Ricordi C, Sanchez J, Clare-Salzler MJ, Padilla N, Fuenmayor V, Chavez C, Alvarez A, Baidal D, Alejandro R, Caprio M, Fabbri A (2019) Influence of vitamin D on islet autoimmunity and beta-cell function in type 1 diabetes. Nutrients 11:2185. https://doi.org/10.3390/nu11092185CrossRefPubMedCentral Infante M, Ricordi C, Sanchez J, Clare-Salzler MJ, Padilla N, Fuenmayor V, Chavez C, Alvarez A, Baidal D, Alejandro R, Caprio M, Fabbri A (2019) Influence of vitamin D on islet autoimmunity and beta-cell function in type 1 diabetes. Nutrients 11:2185. https://​doi.​org/​10.​3390/​nu11092185CrossRefPubMedCentral
8.
Zurück zum Zitat Mathieu C (2011) Vitamin D and the immune system: getting it right. IBMS Bonekey 8:178–186CrossRef Mathieu C (2011) Vitamin D and the immune system: getting it right. IBMS Bonekey 8:178–186CrossRef
9.
Zurück zum Zitat Colin EM, Asmawidjaja PS, van Hamburg JP, Mus AM, van Driel M, Hazes JM, van Leeuwen JP, Lubberts E (2010) 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 62:132–142PubMedCrossRef Colin EM, Asmawidjaja PS, van Hamburg JP, Mus AM, van Driel M, Hazes JM, van Leeuwen JP, Lubberts E (2010) 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 62:132–142PubMedCrossRef
10.
Zurück zum Zitat Scharla S (2008) Diagnosis of disorders of vitamin D‑metabolism and osteomalacia. Clin Lab 54:451–459PubMed Scharla S (2008) Diagnosis of disorders of vitamin D‑metabolism and osteomalacia. Clin Lab 54:451–459PubMed
11.
Zurück zum Zitat Scharla S (2019) Osteomalazie. In: Lehnert H (Hrsg) DGIM Innere Medizin. Springer, Berlin, Heidelberg Scharla S (2019) Osteomalazie. In: Lehnert H (Hrsg) DGIM Innere Medizin. Springer, Berlin, Heidelberg
12.
Zurück zum Zitat Scharla SH, Scheidt-Nave C, Leidig G, Woitge H, Wüster C, Seibel MJ, Ziegler R (1996) Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females. A population-based study. Exp Clin Endocrinol Diabetes 104:289–292PubMedCrossRef Scharla SH, Scheidt-Nave C, Leidig G, Woitge H, Wüster C, Seibel MJ, Ziegler R (1996) Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females. A population-based study. Exp Clin Endocrinol Diabetes 104:289–292PubMedCrossRef
13.
Zurück zum Zitat Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670–676PubMedCrossRef Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337:670–676PubMedCrossRef
14.
Zurück zum Zitat Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 20:315–322PubMedCrossRef Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H (2009) Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 20:315–322PubMedCrossRef
15.
Zurück zum Zitat Chapuy MC, Arlot ME, Duboeuf F et al (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637–1642PubMedCrossRef Chapuy MC, Arlot ME, Duboeuf F et al (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637–1642PubMedCrossRef
16.
Zurück zum Zitat Bolland MJ, Grey A, Avenell A (2018) Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol 6:847–858PubMedCrossRef Bolland MJ, Grey A, Avenell A (2018) Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol 6:847–858PubMedCrossRef
17.
Zurück zum Zitat Appel LJ, Michos E, Mitchell CM, Blackford AL, Sternberg AL, Miller ER, Juraschek SP, Schrack JA, Szanton SL, Charleston J, Minotti M, Baksh SN, Christenson RH, Coresh J, Drye LT, Guralnik JM, Kalyani RR, Plante TB, Shade DM, Roth DL, Tonascia J (2021) The effects of four doses of vitamin D supplements on falls in older adults: a response-adaptive, randomized clinical trial. Ann Intern Med 174:145–156PubMedCrossRef Appel LJ, Michos E, Mitchell CM, Blackford AL, Sternberg AL, Miller ER, Juraschek SP, Schrack JA, Szanton SL, Charleston J, Minotti M, Baksh SN, Christenson RH, Coresh J, Drye LT, Guralnik JM, Kalyani RR, Plante TB, Shade DM, Roth DL, Tonascia J (2021) The effects of four doses of vitamin D supplements on falls in older adults: a response-adaptive, randomized clinical trial. Ann Intern Med 174:145–156PubMedCrossRef
18.
Zurück zum Zitat Sanders KM, Stuart AL, Williamson EJ et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815–1822PubMedCrossRef Sanders KM, Stuart AL, Williamson EJ et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303:1815–1822PubMedCrossRef
20.
Zurück zum Zitat Ginde AA, Blatchford P, Breese K, Zarrabi L, Linnebur SA, Wallace JI, Schwartz RS (2017) High dose monthly vitamin D for prevention of acute respiratory infection in older long-term care residents: a randomized clinical trial. J Am Geriatr Soc 65:496–503PubMedCrossRef Ginde AA, Blatchford P, Breese K, Zarrabi L, Linnebur SA, Wallace JI, Schwartz RS (2017) High dose monthly vitamin D for prevention of acute respiratory infection in older long-term care residents: a randomized clinical trial. J Am Geriatr Soc 65:496–503PubMedCrossRef
21.
Zurück zum Zitat Zheng YT, Cui QQ, Hong YM, Yao WG (2015) A meta-analysis of high dose, intermittent vitamin D supplementation among older adults. PLoS ONE 10:e115850PubMedPubMedCentralCrossRef Zheng YT, Cui QQ, Hong YM, Yao WG (2015) A meta-analysis of high dose, intermittent vitamin D supplementation among older adults. PLoS ONE 10:e115850PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P (2007) Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92:1415–1423PubMedCrossRef Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P (2007) Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92:1415–1423PubMedCrossRef
24.
Zurück zum Zitat Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala N‑B, Clarke A, Franco OH (2010) Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas 65:225–236PubMedCrossRef Parker J, Hashmi O, Dutton D, Mavrodaris A, Stranges S, Kandala N‑B, Clarke A, Franco OH (2010) Levels of vitamin D and cardiometabolic disorders: Systematic review and meta-analysis. Maturitas 65:225–236PubMedCrossRef
25.
Zurück zum Zitat Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO, Dobnig H (2008) Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary Angiography. J Clin Endocrinol Metab 93:3927–3935PubMedCrossRef Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO, Dobnig H (2008) Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary Angiography. J Clin Endocrinol Metab 93:3927–3935PubMedCrossRef
26.
Zurück zum Zitat Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, Grant AM, Campbell MK, Anderson FH, Cooper C, Francis RM, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA, RECORD Trial Group (2012) Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trail). J Clin Endocrinol Metab 97:614–622PubMedCrossRef Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, Grant AM, Campbell MK, Anderson FH, Cooper C, Francis RM, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA, RECORD Trial Group (2012) Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trail). J Clin Endocrinol Metab 97:614–622PubMedCrossRef
28.
Zurück zum Zitat Manson JE, Cook NR, Lee I‑M et al (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 380:33–44PubMedCrossRef Manson JE, Cook NR, Lee I‑M et al (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 380:33–44PubMedCrossRef
29.
Zurück zum Zitat Lee YH, Bae SC (2016) Vitamin D level in rheumatoid arthritis and ist correlation with the disease activity: a meta-analysis. Clin Exp Rheumatol 34:827–833PubMed Lee YH, Bae SC (2016) Vitamin D level in rheumatoid arthritis and ist correlation with the disease activity: a meta-analysis. Clin Exp Rheumatol 34:827–833PubMed
31.
Zurück zum Zitat Scharla SH, Schacht E, Lempert UG (2005) Alfacalcidol versus plain vitamin D in inflammation induced bone loss. J Rheumatol 32(Suppl 76):26–32 Scharla SH, Schacht E, Lempert UG (2005) Alfacalcidol versus plain vitamin D in inflammation induced bone loss. J Rheumatol 32(Suppl 76):26–32
32.
Zurück zum Zitat Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D’Souza C, Ursell M, O’Connor P (2010) A phase 1/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74:1852–1859PubMedPubMedCentralCrossRef Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D’Souza C, Ursell M, O’Connor P (2010) A phase 1/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74:1852–1859PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Smolders J, Torkildsen Ø, Camu W, Holmøy T (2019) An update on vitamin D and disease activity in multiple sclerosis. CNS Drugs 33:1187–1199PubMedPubMedCentralCrossRef Smolders J, Torkildsen Ø, Camu W, Holmøy T (2019) An update on vitamin D and disease activity in multiple sclerosis. CNS Drugs 33:1187–1199PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R (1992) 1,25-dihydroxyvitamin D 3 prevents insulitis in NOD Mice. Diabetes 41:1491–1495PubMedCrossRef Mathieu C, Laureys J, Sobis H, Vandeputte M, Waer M, Bouillon R (1992) 1,25-dihydroxyvitamin D 3 prevents insulitis in NOD Mice. Diabetes 41:1491–1495PubMedCrossRef
36.
Zurück zum Zitat Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R (1994) Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D. Diabetologia 37:552–558PubMedCrossRef Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R (1994) Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D. Diabetologia 37:552–558PubMedCrossRef
37.
Zurück zum Zitat Takiishi T, Ding L, Baeke F, Spagnuolo I, Sebastiani G, Laureys J, Verstuyf A, Carmeliet G, Dotta F, Van Belle TL, Gysemans A, Mathieu C (2014) Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term. Diabetes 63:2026–2036PubMedCrossRef Takiishi T, Ding L, Baeke F, Spagnuolo I, Sebastiani G, Laureys J, Verstuyf A, Carmeliet G, Dotta F, Van Belle TL, Gysemans A, Mathieu C (2014) Dietary supplementation with high doses of regular vitamin D3 safely reduces diabetes incidence in NOD mice when given early and long term. Diabetes 63:2026–2036PubMedCrossRef
38.
Zurück zum Zitat EURODIAB ACE Study Group (2000) Variation and trends in incidence of childhood diabetes in Europe. Lancet 355:873–876CrossRef EURODIAB ACE Study Group (2000) Variation and trends in incidence of childhood diabetes in Europe. Lancet 355:873–876CrossRef
39.
Zurück zum Zitat Mohr SB, Garland CF, Gorham ED, Garland FC (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51:1391–1398PubMedCrossRef Mohr SB, Garland CF, Gorham ED, Garland FC (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51:1391–1398PubMedCrossRef
40.
Zurück zum Zitat Gorham ED, Garland CF, Burgi AA, Mohr SB, Zeng K, Hofflich H (2012) Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nestet case-control study. Diabetologia 55:3224–3227PubMedCrossRef Gorham ED, Garland CF, Burgi AA, Mohr SB, Zeng K, Hofflich H (2012) Lower prediagnostic serum 25-hydroxyvitamin D concentration is associated with higher risk of insulin-requiring diabetes: a nestet case-control study. Diabetologia 55:3224–3227PubMedCrossRef
41.
Zurück zum Zitat Cadario F, Savastio S, Pagliardini V, Bagnati M, Vidali M, Cerutti F (2015) Vitamin D levels at birth and risk of type 1 diabetes in childhood: A case-control study. Acta Diabetol 52:1077–1081PubMedCrossRef Cadario F, Savastio S, Pagliardini V, Bagnati M, Vidali M, Cerutti F (2015) Vitamin D levels at birth and risk of type 1 diabetes in childhood: A case-control study. Acta Diabetol 52:1077–1081PubMedCrossRef
42.
Zurück zum Zitat Mäkinen M, Mykkänen J, Koskinen M, Simell V, Veijola R, Hyöty H (2016) Serum 25-Hydroxyvitamin D concentrations in children progressing to autoimmunity and clinical type 1 diabetes. J Clin Endocrinol Metab 101:723–729PubMedCrossRef Mäkinen M, Mykkänen J, Koskinen M, Simell V, Veijola R, Hyöty H (2016) Serum 25-Hydroxyvitamin D concentrations in children progressing to autoimmunity and clinical type 1 diabetes. J Clin Endocrinol Metab 101:723–729PubMedCrossRef
43.
Zurück zum Zitat Gabbay MAL, Sato MN, Finazzo C, Duarte AJS, Dib SA (2012) Effect of cholecalciferol as adjungtive therapy with insulin on protective immunologic profile and decline of residual b‑cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med 166:601–607PubMedCrossRef Gabbay MAL, Sato MN, Finazzo C, Duarte AJS, Dib SA (2012) Effect of cholecalciferol as adjungtive therapy with insulin on protective immunologic profile and decline of residual b‑cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med 166:601–607PubMedCrossRef
44.
Zurück zum Zitat Treiber G, Prietl B, Fröhlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M, Rami-Merhar B, Steigleder-Schweiger C, Graninger W, Borkenstein M, Pieber TR (2015) Cholecalciferol supplementation improves suppressive capacity of regulatory T‑cells in young patients with new-onset type 1 diabetes mellitus—A randomized clinical trial. Clin Immunol 161:217–224PubMedCrossRef Treiber G, Prietl B, Fröhlich-Reiterer E, Lechner E, Ribitsch A, Fritsch M, Rami-Merhar B, Steigleder-Schweiger C, Graninger W, Borkenstein M, Pieber TR (2015) Cholecalciferol supplementation improves suppressive capacity of regulatory T‑cells in young patients with new-onset type 1 diabetes mellitus—A randomized clinical trial. Clin Immunol 161:217–224PubMedCrossRef
45.
Zurück zum Zitat Penna-Martinez M, Hess H, Doering C, Nejatian N, Bogdanou D, Shoghi F, Hansmann ML, Badenhoop K (2016) High dose vitamin D treatment regulates the gene expression pattern in T‑Helper cells of type 1 diabetes patients. Poster P10-05. Abstract-CD D A C H‑Tagung 2016, 59. Symposium der Deutschen Gesellschaft für Endokrinologie, 21. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel und Frühjahrstagung 2016 der Schweizerischen Gesellschaft für Endokrinologie und Diabetologie – URN: urn:nbn:de:101:1–201604282025.CrossRef Penna-Martinez M, Hess H, Doering C, Nejatian N, Bogdanou D, Shoghi F, Hansmann ML, Badenhoop K (2016) High dose vitamin D treatment regulates the gene expression pattern in T‑Helper cells of type 1 diabetes patients. Poster P10-05. Abstract-CD D A C H‑Tagung 2016, 59. Symposium der Deutschen Gesellschaft für Endokrinologie, 21. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel und Frühjahrstagung 2016 der Schweizerischen Gesellschaft für Endokrinologie und Diabetologie – URN: urn:nbn:de:101:1–201604282025.CrossRef
46.
Zurück zum Zitat Bogdanou D, Penna-Martinez M, Filmann N, Chung TL, Moran-Auth Y, Wehrle J, Cappel C, Huenecke S, Herrmann E, Koehl U, Badenhoop K (2017) T‑lymphocyte and glycemic status after vitamin D treatment in type 1 diabetes: a randomized controlled trial with sequential crossover. Diabetes Metab Res Rev. https://doi.org/10.1002/dmrr.2865CrossRefPubMed Bogdanou D, Penna-Martinez M, Filmann N, Chung TL, Moran-Auth Y, Wehrle J, Cappel C, Huenecke S, Herrmann E, Koehl U, Badenhoop K (2017) T‑lymphocyte and glycemic status after vitamin D treatment in type 1 diabetes: a randomized controlled trial with sequential crossover. Diabetes Metab Res Rev. https://​doi.​org/​10.​1002/​dmrr.​2865CrossRefPubMed
47.
Zurück zum Zitat Mishra A, Dayal D, Sachdeva N, Attri SV (2015) Effect of 6‑months’s vitamin D supplementation on residual beta cell function in children with type 1 diabetes: a case control interventional study. J Pediatr Endocrinol Metab 29:395–400CrossRef Mishra A, Dayal D, Sachdeva N, Attri SV (2015) Effect of 6‑months’s vitamin D supplementation on residual beta cell function in children with type 1 diabetes: a case control interventional study. J Pediatr Endocrinol Metab 29:395–400CrossRef
48.
Zurück zum Zitat Giri D, Pintus D, Burnside G, Ghatak A, Mehta F, Paul P, Senniappan S (2017) Treating vitamin D deficiency in children with type I diabetes could improve their glycaemic control. BMC Res Notes 10:465PubMedPubMedCentralCrossRef Giri D, Pintus D, Burnside G, Ghatak A, Mehta F, Paul P, Senniappan S (2017) Treating vitamin D deficiency in children with type I diabetes could improve their glycaemic control. BMC Res Notes 10:465PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Panjiyar RP, Dayal D, Attri SV, Sachdeva N, Sharma R, Bhalla AK (2018) Sustained serum 25-hydroxyvitamin D concentrations for one year with cholecalciferol supplementation improves glycaemic control and slows the decline of resitual β‑cell function in children with type 1 diabetes. Pediatr Endocrinol Diabetes Metab 24:111–117CrossRef Panjiyar RP, Dayal D, Attri SV, Sachdeva N, Sharma R, Bhalla AK (2018) Sustained serum 25-hydroxyvitamin D concentrations for one year with cholecalciferol supplementation improves glycaemic control and slows the decline of resitual β‑cell function in children with type 1 diabetes. Pediatr Endocrinol Diabetes Metab 24:111–117CrossRef
50.
Zurück zum Zitat Shih EM, Mittelman S, Pitukcheewanont P, Azen CG, Monzavi R (2016) Effects of vitamin D repletion on glycemic control and inflammatory cytokines in adolescents with type 1 diabetes. Pediatr Diabetes 17:36–43PubMedCrossRef Shih EM, Mittelman S, Pitukcheewanont P, Azen CG, Monzavi R (2016) Effects of vitamin D repletion on glycemic control and inflammatory cytokines in adolescents with type 1 diabetes. Pediatr Diabetes 17:36–43PubMedCrossRef
51.
Zurück zum Zitat Sharma S, Biswal N, Bethou A, Rajappa M, Kumar S, Vinayagam V (2017) Does vitamin D supplementation improve glycaemic control in children with type 1 diabetes mellitus?—A randomized controlled trial. J Clin Diagnostic Res 11:SC15–SC17 Sharma S, Biswal N, Bethou A, Rajappa M, Kumar S, Vinayagam V (2017) Does vitamin D supplementation improve glycaemic control in children with type 1 diabetes mellitus?—A randomized controlled trial. J Clin Diagnostic Res 11:SC15–SC17
52.
Zurück zum Zitat Perchard R, Magee L, Whatmore A, Ivison F, Murray P, Stevens A, Mughal MZ, Ehtisham S, Campbell J, Ainsworth S, Marshall M, Bone M, Doughty I, Clayton PE (2017) A pilot interventional study to evaluate the impact of cholecalciferol treatment on HBA1c in type 1 diabetes (T1D). Endocr Connect 6:225–231PubMedPubMedCentralCrossRef Perchard R, Magee L, Whatmore A, Ivison F, Murray P, Stevens A, Mughal MZ, Ehtisham S, Campbell J, Ainsworth S, Marshall M, Bone M, Doughty I, Clayton PE (2017) A pilot interventional study to evaluate the impact of cholecalciferol treatment on HBA1c in type 1 diabetes (T1D). Endocr Connect 6:225–231PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola B, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzari C, Pozzilli P, IMDIAB group (2006) The effects of calcitriol and nicotinamide on residual pancreatic β‑cell function in patients with recent onset type 1 diabetes (IMDIAB XI). Diabetic Med 23:920–923PubMedCrossRef Pitocco D, Crinò A, Di Stasio E, Manfrini S, Guglielmi C, Spera S, Anguissola B, Visalli N, Suraci C, Matteoli MC, Patera IP, Cavallo MG, Bizzari C, Pozzilli P, IMDIAB group (2006) The effects of calcitriol and nicotinamide on residual pancreatic β‑cell function in patients with recent onset type 1 diabetes (IMDIAB XI). Diabetic Med 23:920–923PubMedCrossRef
54.
Zurück zum Zitat Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG (2010) No effect of the 1a,25-dihydroxyvitamin D3 on beta cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 33:1443–1448PubMedPubMedCentralCrossRef Walter M, Kaupper T, Adler K, Foersch J, Bonifacio E, Ziegler AG (2010) No effect of the 1a,25-dihydroxyvitamin D3 on beta cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care 33:1443–1448PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Bizzari C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG, Cappa M, Ghirlanda G, Pozzilli P, IMDIAB Group (2010) No protective effect of calcitriol on β‑cell function in recent-onset type 1 diabetes. Diabetes Care 33:1962–1963CrossRef Bizzari C, Pitocco D, Napoli N, Di Stasio E, Maggi D, Manfrini S, Suraci C, Cavallo MG, Cappa M, Ghirlanda G, Pozzilli P, IMDIAB Group (2010) No protective effect of calcitriol on β‑cell function in recent-onset type 1 diabetes. Diabetes Care 33:1962–1963CrossRef
56.
Zurück zum Zitat Li X, Liao L, Yan X, Huang G, Lin J, Lei M, Wang X, Zhou Z (2009) Protective effects of 1‑alpha-hydroxyvitamin D3 on residual beta cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 25:411–416PubMedCrossRef Li X, Liao L, Yan X, Huang G, Lin J, Lei M, Wang X, Zhou Z (2009) Protective effects of 1‑alpha-hydroxyvitamin D3 on residual beta cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 25:411–416PubMedCrossRef
57.
Zurück zum Zitat Ataie-Jafari A, Loke S‑C, Rahmat AB, Larijani B, Abbasi F, Leow KS, Yassin Z (2013) A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes. Clin Nutr 32:911–917PubMedCrossRef Ataie-Jafari A, Loke S‑C, Rahmat AB, Larijani B, Abbasi F, Leow KS, Yassin Z (2013) A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes. Clin Nutr 32:911–917PubMedCrossRef
58.
Zurück zum Zitat Lempert UG, Scharla SA, Scharla SHJ (2020) Einfluss von Body-Mass-Index, 25-hydroxyvitamin D und HbA1c auf Myostatin. Osteologie 29:50 Lempert UG, Scharla SA, Scharla SHJ (2020) Einfluss von Body-Mass-Index, 25-hydroxyvitamin D und HbA1c auf Myostatin. Osteologie 29:50
59.
Zurück zum Zitat Scharla SH (2020) Knochen und Diabetes mellitus. Osteologie 29:7–12CrossRef Scharla SH (2020) Knochen und Diabetes mellitus. Osteologie 29:7–12CrossRef
60.
Zurück zum Zitat Li X, Liu Y, Zheng Y, Wang P, Zhang Y (2018) The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients 10:375PubMedCentralCrossRef Li X, Liu Y, Zheng Y, Wang P, Zhang Y (2018) The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients 10:375PubMedCentralCrossRef
61.
Zurück zum Zitat Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, LeBlanc ES, Leweis MR, Liao E, Neff LM, Nelson J, O’Neil P, Park J, Peters A, Phillips LS, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Vickery EM, Staten M, for the D2d Research Group (2019) Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med 381:520–530PubMedPubMedCentralCrossRef Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, LeBlanc ES, Leweis MR, Liao E, Neff LM, Nelson J, O’Neil P, Park J, Peters A, Phillips LS, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Vickery EM, Staten M, for the D2d Research Group (2019) Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med 381:520–530PubMedPubMedCentralCrossRef
62.
Zurück zum Zitat Simsek Y, Cakir I, Yetmis M, Dizdar OS, Baspinar O, Gokay F (2016) Effects of vitamin D treatment on thyroid autoimmunity. J Res Med Sci 21:85PubMedPubMedCentralCrossRef Simsek Y, Cakir I, Yetmis M, Dizdar OS, Baspinar O, Gokay F (2016) Effects of vitamin D treatment on thyroid autoimmunity. J Res Med Sci 21:85PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Mazokopakis EE, Papadomanolaki MG, Tsekouras KC, Evangelopoulos AD, Kotsiris DA, Tzortzinis AA (2015) Is vitamin D related to pathogenesis and treatment of Hashimotos’s thyroiditis? Hell J Nucl Med 18:222–227PubMed Mazokopakis EE, Papadomanolaki MG, Tsekouras KC, Evangelopoulos AD, Kotsiris DA, Tzortzinis AA (2015) Is vitamin D related to pathogenesis and treatment of Hashimotos’s thyroiditis? Hell J Nucl Med 18:222–227PubMed
64.
Zurück zum Zitat Chaudhary S, Dutta D, Kumar M, Saha S, Mondal SA, Kumar A, Mukhopadhyay S (2016) Vitamin D supplementation reduces thyroid peroxidase antibody levels in patients with autoimmune thyroid disease: an open-labeled randomized controlled trial. Indian J Endocrinol Metab 20:391–398PubMedPubMedCentralCrossRef Chaudhary S, Dutta D, Kumar M, Saha S, Mondal SA, Kumar A, Mukhopadhyay S (2016) Vitamin D supplementation reduces thyroid peroxidase antibody levels in patients with autoimmune thyroid disease: an open-labeled randomized controlled trial. Indian J Endocrinol Metab 20:391–398PubMedPubMedCentralCrossRef
65.
Zurück zum Zitat Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, Baggerly K, McDonnel SL (2017) Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA 317:1234–1243PubMedCrossRef Lappe J, Watson P, Travers-Gustafson D, Recker R, Garland C, Gorham E, Baggerly K, McDonnel SL (2017) Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA 317:1234–1243PubMedCrossRef
66.
Zurück zum Zitat Scharla SH (2019) Vitamin D in der Reproduktionsmedizin. Gynäkologische Endokrinologie 17:16–19CrossRef Scharla SH (2019) Vitamin D in der Reproduktionsmedizin. Gynäkologische Endokrinologie 17:16–19CrossRef
67.
Zurück zum Zitat Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Meim CA, Bhaw-Rosun L, Nuamah R, Young DB, Drobniewski FA, Griffiths CJ, Martineau AR (2012) Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A 109:15449–15454PubMedPubMedCentralCrossRef Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Meim CA, Bhaw-Rosun L, Nuamah R, Young DB, Drobniewski FA, Griffiths CJ, Martineau AR (2012) Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A 109:15449–15454PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Bergmann P, Lindh AU, Björkhem-Bergman L, Lindh JD (2013) Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. Plos One 8:e65835CrossRef Bergmann P, Lindh AU, Björkhem-Bergman L, Lindh JD (2013) Vitamin D and respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials. Plos One 8:e65835CrossRef
69.
Zurück zum Zitat Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Janssens W, Jensen ME, Kerley CP, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S, Stelmach I, Kumar GT, Uraschima M, Camargo CA, Griffiths CJ, Hooper RL (2019) Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess 23:1–44PubMedPubMedCentralCrossRef Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Janssens W, Jensen ME, Kerley CP, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S, Stelmach I, Kumar GT, Uraschima M, Camargo CA, Griffiths CJ, Hooper RL (2019) Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess 23:1–44PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Pham H, Waterhouse M, Baxter C, Romero BD, McLeod DSA, Armstrong BK et al (2021) The effect of vitamin D supplementation on acute respiratory tract infection in older Australian adults: an analysis of data from the D‑Health Trial. Lancet Diabetes Endocrinol 9:69–81PubMedCrossRef Pham H, Waterhouse M, Baxter C, Romero BD, McLeod DSA, Armstrong BK et al (2021) The effect of vitamin D supplementation on acute respiratory tract infection in older Australian adults: an analysis of data from the D‑Health Trial. Lancet Diabetes Endocrinol 9:69–81PubMedCrossRef
71.
Zurück zum Zitat Martineau AR, James WY, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, Islam K, McLaughlin D, Bhowmik A, Timms PM, Rajajulasingam RK, Rowe M, Venton TR, Choudhury AB, Simcock DE, Wilks M, Degun A, Sadique Z, Monteiro WR, Corrigan CJ, Hawrylowicz CM, Griffiths CJ (2015) Vitamin D supplementation in patients with chronic obstructive pulmonary disease (ViDiCo): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 3:120–130. https://doi.org/10.1016/S2213-2600(14)70255-3CrossRefPubMed Martineau AR, James WY, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, Islam K, McLaughlin D, Bhowmik A, Timms PM, Rajajulasingam RK, Rowe M, Venton TR, Choudhury AB, Simcock DE, Wilks M, Degun A, Sadique Z, Monteiro WR, Corrigan CJ, Hawrylowicz CM, Griffiths CJ (2015) Vitamin D supplementation in patients with chronic obstructive pulmonary disease (ViDiCo): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med 3:120–130. https://​doi.​org/​10.​1016/​S2213-2600(14)70255-3CrossRefPubMed
72.
Zurück zum Zitat Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91:1255–1260PubMedCrossRef Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91:1255–1260PubMedCrossRef
74.
Zurück zum Zitat Xu Yi, Baylink DJ, Chen CS, Reeves ME, Xiao J, Lacy C, Lau E, Cao H (2020) The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med 18:322PubMedPubMedCentralCrossRef Xu Yi, Baylink DJ, Chen CS, Reeves ME, Xiao J, Lacy C, Lau E, Cao H (2020) The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med 18:322PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Merzon E, Tworowski D, Gorohovski A, Vinker S, Cohen AG, Green I, Frenkel-Morgenstern (2020) Low plasma 25(OH)vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J 287:3693–3702PubMedCrossRef Merzon E, Tworowski D, Gorohovski A, Vinker S, Cohen AG, Green I, Frenkel-Morgenstern (2020) Low plasma 25(OH)vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J 287:3693–3702PubMedCrossRef
77.
Zurück zum Zitat Hernandez JL, Nan D, Fernandez-Ayala M, Garcia-Unzueta M, Hernandez-Hernandez MA, Lopez-Hoyos M, Munoz-Ccho P, Omos JM, Gutierrez-Cuadra M, Ruiz-Cubillan JJ, Crespo J, Marinez-Taboada VM (2020) Vitamin D status in hospitalized patients with SARS-coV‑2 infection. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgaa733CrossRef Hernandez JL, Nan D, Fernandez-Ayala M, Garcia-Unzueta M, Hernandez-Hernandez MA, Lopez-Hoyos M, Munoz-Ccho P, Omos JM, Gutierrez-Cuadra M, Ruiz-Cubillan JJ, Crespo J, Marinez-Taboada VM (2020) Vitamin D status in hospitalized patients with SARS-coV‑2 infection. J Clin Endocrinol Metab. https://​doi.​org/​10.​1210/​clinem/​dgaa733CrossRef
78.
Zurück zum Zitat Hutchings N, Babalyan V, Baghdasaryan S, Qefoyan M, Sargsyants N, Aghajanova E, Martirosyan A, Harutyunyan R, Lesnyak O, Formenti AM, Giustina A, Bilezikian JP (2021) Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D. Endocrine 16:1–3. https://doi.org/10.1007/s12020-020-02597-7CrossRef Hutchings N, Babalyan V, Baghdasaryan S, Qefoyan M, Sargsyants N, Aghajanova E, Martirosyan A, Harutyunyan R, Lesnyak O, Formenti AM, Giustina A, Bilezikian JP (2021) Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D. Endocrine 16:1–3. https://​doi.​org/​10.​1007/​s12020-020-02597-7CrossRef
79.
Zurück zum Zitat Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D, Boot CS, Stock N, Macfarlane J, Martineau AR, Burns G, Quinton R (2020) Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol 93:508–511CrossRef Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D, Boot CS, Stock N, Macfarlane J, Martineau AR, Burns G, Quinton R (2020) Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol 93:508–511CrossRef
80.
Zurück zum Zitat Vassiliou AG, Jahaj E, Pratikaki M, Orfanos SE, Dimopoulou I, Kotanidou A (2020) Low 25-Hydroxyvitamin D levels on admission to the intensive care unit may predispose COVID-19 pneumonia patients to a higher 28-day mortality risk: a pilot study on a greek ICU cohort. Nutrients 12:3773PubMedCentralCrossRef Vassiliou AG, Jahaj E, Pratikaki M, Orfanos SE, Dimopoulou I, Kotanidou A (2020) Low 25-Hydroxyvitamin D levels on admission to the intensive care unit may predispose COVID-19 pneumonia patients to a higher 28-day mortality risk: a pilot study on a greek ICU cohort. Nutrients 12:3773PubMedCentralCrossRef
81.
Zurück zum Zitat Karahan S, Katkat F (2021) Impact of serum 25(OH)Vitamin D level on mortality in patients with COVID-19 in Turkey. J Nutr Health Aging 25:189–196PubMedCrossRef Karahan S, Katkat F (2021) Impact of serum 25(OH)Vitamin D level on mortality in patients with COVID-19 in Turkey. J Nutr Health Aging 25:189–196PubMedCrossRef
82.
83.
Zurück zum Zitat Orchard L, Baldry M, Nasim-Mohi M, Monck C, Saeed K, Grocott MPW, Ahilanandan D, University Hospital Southampton Critical Care Team and the REACT COVID Investigators (2021) Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients. Clin Chem Lab Med. https://doi.org/10.1515/cclm-2020-1567CrossRefPubMed Orchard L, Baldry M, Nasim-Mohi M, Monck C, Saeed K, Grocott MPW, Ahilanandan D, University Hospital Southampton Critical Care Team and the REACT COVID Investigators (2021) Vitamin D levels and intensive care unit outcomes of a cohort of critically ill COVID-19 patients. Clin Chem Lab Med. https://​doi.​org/​10.​1515/​cclm-2020-1567CrossRefPubMed
84.
Zurück zum Zitat Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz C, Jani BD, Welsh P, Mair FS, Gray SR, O’Donnell CA, Gill JMR, Sattar N, Pell JP (2020) Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr 14:561–565PubMedPubMedCentralCrossRef Hastie CE, Mackay DF, Ho F, Celis-Morales CA, Katikireddi SV, Niedzwiedz C, Jani BD, Welsh P, Mair FS, Gray SR, O’Donnell CA, Gill JMR, Sattar N, Pell JP (2020) Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr 14:561–565PubMedPubMedCentralCrossRef
86.
Zurück zum Zitat Ohaegbulam KC, Swalih M, Patel P, Smith MA, Perrin R (2020) Vitamin D supplementation in COVID-19 patients: a clinical case series. Am J Ther 27:e485–e490PubMedCrossRef Ohaegbulam KC, Swalih M, Patel P, Smith MA, Perrin R (2020) Vitamin D supplementation in COVID-19 patients: a clinical case series. Am J Ther 27:e485–e490PubMedCrossRef
87.
88.
Zurück zum Zitat Annweiler C, Hanotte B, de lÉprevier C, Sabatier JM, Lafaie L, Célarier T (2020) Vitamin D and survival in COVID-19 patients: a quasi-experimental study. J Steroid Biochem Mol Biol 204:105771PubMedPubMedCentralCrossRef Annweiler C, Hanotte B, de lÉprevier C, Sabatier JM, Lafaie L, Célarier T (2020) Vitamin D and survival in COVID-19 patients: a quasi-experimental study. J Steroid Biochem Mol Biol 204:105771PubMedPubMedCentralCrossRef
89.
Zurück zum Zitat Castillo ME, Costa LME, Barrios JMV, Diaz JFA, Miranda JL, Bouillon R, Gomez JMQ (2020) Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol 203:105751CrossRef Castillo ME, Costa LME, Barrios JMV, Diaz JFA, Miranda JL, Bouillon R, Gomez JMQ (2020) Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol 203:105751CrossRef
Metadaten
Titel
Pleiotrope Wirkung von Vitamin D mit Berücksichtigung von COVID-19
verfasst von
PD Dr. med. habil. Stephan H. Scharla
Publikationsdatum
17.03.2021
Verlag
Springer Vienna
Erschienen in
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen / Ausgabe 1/2021
Print ISSN: 2412-8260
Elektronische ISSN: 2412-8287
DOI
https://doi.org/10.1007/s41970-021-00146-w

Weitere Artikel der Ausgabe 1/2021

Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen 1/2021 Zur Ausgabe

Editorial

Editorial

News-Screen Physikalische Medizin

News-Screen Physikalische Medizin

Mitteilungen der ÖGKM

Mitteilungen der ÖGKM

News-Screen Rheumatologie

News-Screen Rheumatologie